AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9481978 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: alfentanil, N2O, O2 with 0.25% isoflurane
Number of subjects: 119
Study 9481978 — intervention group
Group type: COMPARATOR
Intervention: Group B: oxygen, room air, isoflurane, and alfentanil
Number of subjects: 119
Study 8306013 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin plus ergometrine (Syntometrine: 5 units of oxytocin with 0.5 mg of ergometrine)
Number of subjects: 461
Study 8306013 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin alone (5 units of Syntocinon)
Number of subjects: 461
Study 3521532 — intervention group
Group type: EXPERIMENTAL
Intervention: Haloperidol (n = 21), mean dose 7.24 mg, 4 to 16 mg range
Number of subjects: 61
Study 3521532 — intervention group
Group type: EXPERIMENTAL
Intervention: Amitriptyline (n = 20), mean dose 147.62 mg, 100 to 175 mg range
Number of subjects: 61
Study 3521532 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 20)
Number of subjects: 61
Study 29155807 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoallergenic, nutritionally complete amino-acid-based formula including a prebiotic blend of fructo-oligosaccharides and the probiotic strain Bifidobacterium breve M-16V (test group)
Number of subjects: 71
Study 29155807 — intervention group
Group type: COMPARATOR
Intervention: Amino-acid-based formula without synbiotics (control group)
Number of subjects: 71
Study 28486519 — intervention group
Group type: EXPERIMENTAL
Intervention: Lamivudine
Number of subjects: 1216
Study 28486519 — intervention group
Group type: EXPERIMENTAL
Intervention: Lopinavir/Ritonavir
Number of subjects: 1216
Study 26700937 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg of atorvastatin once daily for 2 years
Number of subjects: 350
Study 26700937 — intervention group
Group type: COMPARATOR
Intervention: Identical placebo once daily for 2 years
Number of subjects: 350
Study 22936298 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyether (PE: Impregum Penta H/L DuoSoft Quick, 3 M ESPE) with manufacturer's recommended working time
Number of subjects: 96
Study 22936298 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition-curing silicone (AS: Aquasil Ultra LV, Dentsply/DeTrey) with manufacturer's recommended working time
Number of subjects: 96
Study 22936298 — intervention group
Group type: EXPERIMENTAL
Intervention: Addition-curing silicone (AS) with altered working times
Number of subjects: 96
Study 22936298 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyether (PE) with altered working times
Number of subjects: 96
Study 20645670 — intervention group
Group type: EXPERIMENTAL
Intervention: Lithium
Number of subjects: 55
Study 20645670 — intervention group
Group type: COMPARATOR
Intervention: Non-lithium
Number of subjects: 55
Study 18972768 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral feeding through a nasojejunal tube initiated 12 hours after surgery
Number of subjects: 61
Study 18972768 — intervention group
Group type: EXPERIMENTAL
Intervention: Early enteral feeding through a nasojejunal tube
Number of subjects: 61
Study 18972768 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without early enteral feeding)
Number of subjects: 61
Study 17006324 — intervention group
Group type: EXPERIMENTAL
Intervention: CsA plus atorvastatin
Number of subjects: 12
Study 17006324 — intervention group
Group type: EXPERIMENTAL
Intervention: TRL alone
Number of subjects: 12
Study 17006324 — intervention group
Group type: EXPERIMENTAL
Intervention: TRL plus atorvastatin
Number of subjects: 12
Study 17006324 — intervention group
Group type: COMPARATOR
Intervention: CsA alone
Number of subjects: 12
Study 14698826 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound dating service
Number of subjects: 3009
Study 14698826 — intervention group
Group type: COMPARATOR
Intervention: Control unit (obstetric ultrasound only for specific indications)
Number of subjects: 3009
Study 12608196 — intervention group
Group type: EXPERIMENTAL
Intervention: Fuji IX glass-ionomer cement
Number of subjects: 1325
Study 12608196 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketac-MOLAR (hand mix)
Number of subjects: 1325
Study 12608196 — intervention group
Group type: EXPERIMENTAL
Intervention: ART approach (general)
Number of subjects: 1325
Study 9330931 — intervention group
Group type: EXPERIMENTAL
Intervention: Short‐Form Health Survey (SF‐36)
Number of subjects: 48
Study 9330931 — intervention group
Group type: EXPERIMENTAL
Intervention: Joint tenderness score
Number of subjects: 48
Study 9330931 — intervention group
Group type: EXPERIMENTAL
Intervention: Physician global assessment
Number of subjects: 48
Study 9330931 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient global assessment
Number of subjects: 48
Study 8376571 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural morphine (EM)
Number of subjects: 40
Study 8376571 — intervention group
Group type: COMPARATOR
Intervention: Patient-controlled analgesia with morphine
Number of subjects: 40
Study 3532602 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-stable 17D yellow fever vaccine
Number of subjects: 258
Study 3532602 — intervention group
Group type: COMPARATOR
Intervention: Non-stabilized yellow fever vaccine
Number of subjects: 258
Study 29128416 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical tranexamic acid
Number of subjects: 119
Study 29128416 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 119
Study 27058396 — intervention group
Group type: EXPERIMENTAL
Intervention: T'ai chi chuan
Number of subjects: 7
Study 27058396 — intervention group
Group type: COMPARATOR
Intervention: Control session
Number of subjects: 7
Study 24606601 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-management group intervention (eight weekly sessions, 90 minutes each)
Number of subjects: 42
Study 24606601 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 42
Study 22353025 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-monitoring (open vs. blinded Omron-HJ-113-E pedometer)
Number of subjects: 10
Study 22353025 — intervention group
Group type: EXPERIMENTAL
Intervention: Goal-setting (step-count goal prompt vs. alternative goal prompt)
Number of subjects: 10
Study 22353025 — intervention group
Group type: COMPARATOR
Intervention: Goal-setting
Number of subjects: 10
Study 22353025 — intervention group
Group type: COMPARATOR
Intervention: Self-monitoring
Number of subjects: 10
Study 22353025 — intervention group
Group type: EXPERIMENTAL
Intervention: Time
Number of subjects: 10
Study 20507732 — intervention group
Group type: EXPERIMENTAL
Intervention: CIK cell transfusion (intravenously or via common hepatic arteries, every week for at least 4 times)
Number of subjects: 122
Study 20507732 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CIK cell transfusion)
Number of subjects: 122
Study 20507732 — intervention group
Group type: EXPERIMENTAL
Intervention: CIK cell transfusion
Number of subjects: 122
Study 18728513 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization at 3 hours after sheath removal
Number of subjects: 304
Study 18728513 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization at 4 hours after sheath removal
Number of subjects: 304
Study 18728513 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobilization at 6 hours after sheath removal
Number of subjects: 304
Study 16372825 — intervention group
Group type: EXPERIMENTAL
Intervention: FEBT 200 microg
Number of subjects: 25
Study 16372825 — intervention group
Group type: EXPERIMENTAL
Intervention: FEBT 500 microg
Number of subjects: 25
Study 16372825 — intervention group
Group type: EXPERIMENTAL
Intervention: FEBT 810 microg
Number of subjects: 25
Study 16372825 — intervention group
Group type: EXPERIMENTAL
Intervention: FEBT 1080 microg
Number of subjects: 25
Study 16372825 — intervention group
Group type: EXPERIMENTAL
Intervention: FEBT 200-1080 microg
Number of subjects: 25
Study 12090967 — intervention group
Group type: EXPERIMENTAL
Intervention: Rochester AIDS Prevention Project curriculum taught by peer educators
Number of subjects: 1352
Study 12090967 — intervention group
Group type: EXPERIMENTAL
Intervention: Rochester AIDS Prevention Project curriculum taught by regular teachers
Number of subjects: 1352
Study 12090967 — intervention group
Group type: COMPARATOR
Intervention: Regular school health curriculum (Control)
Number of subjects: 1352
Study 11156963 — intervention group
Group type: EXPERIMENTAL
Intervention: Resistance exercise for 3 months
Number of subjects: 2
Study 11156963 — intervention group
Group type: COMPARATOR
Intervention: Non-exercising control group
Number of subjects: 2
Study 9438888 — intervention group
Group type: EXPERIMENTAL
Intervention: Popliteal block (30 ml of alkalinized 3% chloroprocaine) and posterior cutaneous nerve of the thigh block (10 ml of 1% lidocaine)
Number of subjects: 28
Study 9438888 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (65 mg of 5% hyperbaric lidocaine)
Number of subjects: 28
Study 8235870 — intervention group
Group type: EXPERIMENTAL
Intervention: Extension treatment
Number of subjects: 56
Study 8235870 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexion treatment
Number of subjects: 56
Study 8235870 — intervention group
Group type: COMPARATOR
Intervention: Placebo-control treatment
Number of subjects: 56
Study 3680597 — intervention group
Group type: EXPERIMENTAL
Intervention: 4-g dose of mezlocillin
Number of subjects: 12
Study 3680597 — intervention group
Group type: EXPERIMENTAL
Intervention: 5-g dose of mezlocillin
Number of subjects: 12
Study 30619530 — intervention group
Group type: EXPERIMENTAL
Intervention: Experiential module incorporating 10-minute practices of yoga, biofeedback, and acupressure
Number of subjects: 38
Study 30619530 — intervention group
Group type: COMPARATOR
Intervention: Standard lecture focused on CAIM use and outcomes
Number of subjects: 38
Study 27133008 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic sling or transobturator sling for stress urinary incontinence
Number of subjects: 526
Study 24532039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg twice daily (after switching from imatinib)
Number of subjects: 54
Study 24532039 — intervention group
Group type: EXPERIMENTAL
Intervention: Nilotinib 400 mg twice daily (after switching from nilotinib 300 mg)
Number of subjects: 54
Study 21740603 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-led intervention group (cognitive behavioural training)
Number of subjects: 50
Study 21740603 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 50
Study 21740603 — intervention group
Group type: EXPERIMENTAL
Intervention: All children (after intervention)
Number of subjects: 50
Study 21740603 — intervention group
Group type: COMPARATOR
Intervention: Reference group
Number of subjects: 50
Study 21740603 — intervention group
Group type: EXPERIMENTAL
Intervention: Parents' report
Number of subjects: 50
Study 20197582 — intervention group
Group type: EXPERIMENTAL
Intervention: Antithrombotic therapy (including antiplatelet and antithrombin agents)
Number of subjects: 0
Study 20197582 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleeding complications
Number of subjects: 0
Study 20197582 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacological and nonpharmacological strategies
Number of subjects: 0
Study 20197582 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleeding
Number of subjects: 0
Study 18597899 — intervention group
Group type: EXPERIMENTAL
Intervention: Lento music intervention (40-min group-based)
Number of subjects: 38
Study 18597899 — intervention group
Group type: COMPARATOR
Intervention: Silence (regular test without music)
Number of subjects: 38
Study 15739719 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 15‐minute oral stimulation program for 10 days before the start of oral feedings
Number of subjects: 32
Study 15739719 — intervention group
Group type: COMPARATOR
Intervention: Control group (no oral stimulation program)
Number of subjects: 32
Study 14969216 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate non-occlusal loading of dental implants
Number of subjects: 0
Study 14969216 — intervention group
Group type: COMPARATOR
Intervention: Early loading protocol
Number of subjects: 0
Study 10651785 — intervention group
Group type: EXPERIMENTAL
Intervention: IFT 3 (10‐20 Hz beat frequency)
Number of subjects: 50
Study 10651785 — intervention group
Group type: COMPARATOR
Intervention: Control (no suction nor interferential current applied)
Number of subjects: 50
Study 8635262 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-apheresis plus medication (simvastatin 40 mg/day)
Number of subjects: 42
Study 8635262 — intervention group
Group type: COMPARATOR
Intervention: Medication alone (simvastatin 40 mg/day)
Number of subjects: 42
Study 8635262 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL-apheresis plus medication
Number of subjects: 42
Study 8635262 — intervention group
Group type: COMPARATOR
Intervention: Medication alone
Number of subjects: 42
Study 2063706 — intervention group
Group type: EXPERIMENTAL
Intervention: Early triers (students who tried one or more cigarettes)
Number of subjects: 1663
Study 2063706 — intervention group
Group type: COMPARATOR
Intervention: Never-triers (students who never tried a cigarette)
Number of subjects: 1663
Study 2063706 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychosocial characteristics
Number of subjects: 1663
Study 31245901 — intervention group
Group type: EXPERIMENTAL
Intervention: NPWT with saline irrigation (NPWT-I)
Number of subjects: 90
Study 31245901 — intervention group
Group type: COMPARATOR
Intervention: Traditional NPWT device (NPWT-C)
Number of subjects: 90
Study 31245901 — intervention group
Group type: COMPARATOR
Intervention: Traditional NPWT device (NPWT-K)
Number of subjects: 90
Study 30298422 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity tracking wristband feedback
Number of subjects: 132
Study 30298422 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback)
Number of subjects: 132
Study 30298422 — intervention group
Group type: EXPERIMENTAL
Intervention: Both intervention and control groups
Number of subjects: 132
Study 29237497 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) levels in serum and bronchoalveolar lavage fluid (BALF)
Number of subjects: 86
Study 29237497 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic acid (HA) levels in serum and BALF
Number of subjects: 86
Study 26490099 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking cessation (quitters)
Number of subjects: 937
Study 26490099 — intervention group
Group type: COMPARATOR
Intervention: Continuing smokers (control)
Number of subjects: 937
Study 23335150 — intervention group
Group type: EXPERIMENTAL
Intervention: CONNECT with physician summary
Number of subjects: 743
Study 23335150 — intervention group
Group type: EXPERIMENTAL
Intervention: CONNECT without physician summary
Number of subjects: 743
Study 23335150 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 743
Study 21556784 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephonic quitline intervention (counseling and nicotine replacement therapy)
Number of subjects: 0
Study 21556784 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-based group counseling intervention
Number of subjects: 0
Study 21556784 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions (quitline and group counseling)
Number of subjects: 0
Study 21556784 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 19382469 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrative medical regimen (IMR) - Jiangya Capsule (JYC) and Nimodipine (ND)
Number of subjects: 135
Study 19382469 — intervention group
Group type: COMPARATOR
Intervention: JYC plus ND simulator (Group B)
Number of subjects: 135
Study 19382469 — intervention group
Group type: COMPARATOR
Intervention: ND plus JYC simulator (Group C)
Number of subjects: 135
Study 17097698 — intervention group
Group type: EXPERIMENTAL
Intervention: Insecticide-treated bednets (ITNs)
Number of subjects: 19679
Study 17097698 — intervention group
Group type: COMPARATOR
Intervention: Interruption of ITN intervention
Number of subjects: 19679
Study 14760542 — intervention group
Group type: EXPERIMENTAL
Intervention: Progressive muscle relaxation (n=80)
Number of subjects: 229
Study 14760542 — intervention group
Group type: EXPERIMENTAL
Intervention: Autogenic training (n=71)
Number of subjects: 229
Study 14760542 — intervention group
Group type: COMPARATOR
Intervention: Standard rehabilitation programme (Control group, n=78)
Number of subjects: 229
Study 12365016 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy with mitomycin C (6 mg/m(2) i.v.) and 5‐fluorouracil (310 mg/m(2) i.v.) for 5 consecutive days during postoperative Weeks 1 and 3, followed by 5‐FU (100 mg/m(2) orally) daily from postoperative Week 5 until disease recurrence.
Number of subjects: 112
Study 12365016 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative adjuvant chemotherapy with mitomycin C and 5‐fluorouracil.
Number of subjects: 112
Study 9658721 — intervention group
Group type: EXPERIMENTAL
Intervention: CD117 antigen expression (clone 95C3) determined by flow cytometry in AML patients
Number of subjects: 135
Study 9658721 — intervention group
Group type: EXPERIMENTAL
Intervention: CD117 antigen expression in M5 subtype
Number of subjects: 135
Study 9658721 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation analysis of CD117 with other antigens
Number of subjects: 135
Study 9658721 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface expression of CD117 in ALL
Number of subjects: 135
Study 7648285 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine (200 mg every 8 h for 3 days)
Number of subjects: 6
Study 7648285 — intervention group
Group type: EXPERIMENTAL
Intervention: Didanosine (200 mg every 12 h for 3 days)
Number of subjects: 6
Study 7648285 — intervention group
Group type: EXPERIMENTAL
Intervention: Zidovudine and didanosine coadministered for 3 days
Number of subjects: 6
Study 2649867 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytetracycline, Doxycycline, Rifampin (oral monotherapy)
Number of subjects: 1100
Study 2649867 — intervention group
Group type: EXPERIMENTAL
Intervention: TMP/SMX (oral monotherapy)
Number of subjects: 1100
Study 2649867 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin plus Oxytetracycline (combined oral therapy)
Number of subjects: 1100
Study 2649867 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampin plus TMP/SMX (combined oral therapy)
Number of subjects: 1100
Study 2649867 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytetracycline plus TMP/SMX (combined oral therapy)
Number of subjects: 1100
Study 2649867 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral monotherapy combined with Streptomycin
Number of subjects: 1100
Study 2649867 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral monotherapy combined with Gentamicin
Number of subjects: 1100
Study 322791 — intervention group
Group type: EXPERIMENTAL
Intervention: Xenon-arc photocoagulation
Number of subjects: 100
Study 322791 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated eye)
Number of subjects: 100
Study 30596530 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-ARS training (30 minutes, thrice per week for 4 weeks)
Number of subjects: 36
Study 30596530 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical fitness program (thrice per week for 1 month)
Number of subjects: 36
Study 27647603 — intervention group
Group type: EXPERIMENTAL
Intervention: Orthosis group
Number of subjects: 25
Study 27647603 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study 27647603 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 25
Study 24825404 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc sulfate (220 mg/d)
Number of subjects: 36
Study 24825404 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study 23369983 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive rehabilitation (CR) for 8 weeks
Number of subjects: 19
Study 23369983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 19
Study 21377034 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut OIT (peanut flour)
Number of subjects: 28
Study 21377034 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 18029344 — intervention group
Group type: EXPERIMENTAL
Intervention: Sevoflurane (SEVO)
Number of subjects: 30
Study 18029344 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol (PRO)
Number of subjects: 30
Study 18029344 — intervention group
Group type: COMPARATOR
Intervention: Spinal anaesthesia (SA)
Number of subjects: 30
Study 16756424 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 149
Study 16756424 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone (targeted fashion)
Number of subjects: 149
Study 16756424 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 149
Study 15083598 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous glycoprotein IIb/IIIa inhibitors
Number of subjects: 100
Study 10998012 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA‐DRB1*0701 allele
Number of subjects: 181
Study 10998012 — intervention group
Group type: EXPERIMENTAL
Intervention: HLA‐DRB1*0701 allele and D14S50 allele 170
Number of subjects: 181
Study 10998012 — intervention group
Group type: COMPARATOR
Intervention: D14S50 alleles alone
Number of subjects: 181
Study 9498150 — intervention group
Group type: EXPERIMENTAL
Intervention: Transtrochanteric approach
Number of subjects: 264
Study 9498150 — intervention group
Group type: COMPARATOR
Intervention: Liverpool approach
Number of subjects: 264
Study 9498150 — intervention group
Group type: COMPARATOR
Intervention: Hardinge approach
Number of subjects: 264
Study 7900936 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine (100 micrograms)
Number of subjects: 37
Study 7900936 — intervention group
Group type: EXPERIMENTAL
Intervention: Iodine (200 micrograms)
Number of subjects: 37
Study 2877682 — intervention group
Group type: EXPERIMENTAL
Intervention: Vecuronium 0.1 mg kg‐1
Number of subjects: 10
Study 2877682 — intervention group
Group type: EXPERIMENTAL
Intervention: Atracurium 0.5 mg kg‐1
Number of subjects: 10
Study 2877682 — intervention group
Group type: EXPERIMENTAL
Intervention: Tubocurarine 0.5 mg kg‐1
Number of subjects: 10
Study 29590380 — intervention group
Group type: EXPERIMENTAL
Intervention: 10-item Moral Injury Symptom Scale - Military Version Short Form (MISS-M-SF)
Number of subjects: 427
Study 27392430 — intervention group
Group type: EXPERIMENTAL
Intervention: Self‐monitoring and feedback; action planning; normative feedback; cognitive bias re‐training; identity change (delivered via the 'Drink Less' app)
Number of subjects: 0